The diagnostic value of glycogen, mucin, carbonhydrate antigen 19-9, and carcinoembryonic antigen in aspirated cyst fluid in cystic lesions of pancreas

Year 2015, Volume: 20 Issue: 2, 65 - 69, 10.07.2015

Osman Toktaş , Alpaslan Yavuz Gülay Bulut Sıddık Keskin Ümit İliklerden M. Çetin Kotan

Abstract

Abstract:

Objective: The aim of the present study was to evaluate diagnostic value of glycogen and mucin-staining features of aspirated cyst fluid, and carbonhydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) levels in the blood and cyst fluid in differentiating benign from malignant lesions.

Materials and Methods: A total of 13 patients, who were referred to the General Surgery Clinics due to pancreatic lesion between January 2013 and November 2013, were included in the study. In the preoperative period, CA 19-9 and CEA were obtained from all patients. The cyst fluid was aspirated in the guidance of radiological imaging methods in 6 methods and using laparoscopic or surgical methods in 7 patients. CA 19-9 and CEA levels were evaluated in the aspirated cyst fluids, and immunohistochemical tests were performed using PAS (glycogen) and mucin staining in patients with sufficient cyst fluid. The pancreatic tissue was macroscopically evaluated in patients who underwent an operation, and appropriate procedure was selected depending on the location of the lesion.

Results: The pathological examination of the 13 patients revealed malignant lesion in 5, benign-inflammatory cyst (IC) in 5, serous cystic neoplasm (CSN) in 1, mucinous cystic neoplasm (MCN) in 1, and non-functional cystic neuroendocrine tumor (CNT) in 1. The blood tests performed in 5 patients with malignant findings on pathological examination revealed elevated CEA levels in 1 patient and elevated CA 19-9 levels in 3 patients. In the aspirated cyst fluids, CA 19-9 levels were high in 3 patients with malignant lesion and in patients with MCN and CNT. The immunohistochemical examination revealed positive staining for PAS and mucin in 2 patients with malignant lesion and one patient with MCN, and another patient with malignant lesion showed PAS-positive staining. Immunohistochemical examination involving PAS and mucin could not be performed in two patients one of which had malignant lesion due to insufficient aspiration fluid.

Conclusion: In the present study, CA 19-9 levels in the blood and aspirated cyst fluids were found to be higher in patients with malignant pancreatic lesions. Of patients with malignant lesions, 3 showed positive PAS staining. However, long-term studies on larger series of patients are warranted in order to establish the diagnostic value of PAS-staining and mucin-staining in immunohistochemical examination of the cyst fluids and the value of CEA levels in the blood and aspirated cyst fluid.

Keywords

Pancreas, cystic neoplasm, pancreas mucinous neoplasia

References

• Federle MP, McGrath KM. Cystic neoplasms of the pancreas. Gastroenterol Clin North Am 2007; 36:365-376.
• Fernández-del Castillo C, Targarona J, Thayer SP, et al. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg 2003; 138:427-423.
• Society for Surgery of the Alimentary Tract. SSAT patient care guidelines. Cystic neoplasms of the pancreas. J Gastrointest Surg 2007; 11:1225-1227.
• Hernandez LV, Mishra G, Forsmark C, et al. Role of endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration in the diagnosis and treatment of cystic lesions of the pancreas. Pancreas 2002; 25:222-228.
• Brugge WR, Lauwers GY, Sahani D, Fernandez-del Castillo C, Warshaw AL. Cystic neoplasms of the pancreas. N Engl J Med 2004; 351:1218-1226.
• Oh HC, Kim MH, Hwang CY, et al. Cystic lesions of the pancreas: challenging issues in clinical practice. Am J Gastroenterol 2008; 103:229-239.
• Yamao K, Nakamura T, Suzuki T, et al. Endoscopic diagnosis and staging of mucinous cystic neoplasms and intraductal papillary-mucinous tumors. J Hepatobiliary Pancreat Surg 2003; 10:142-146.
• Sedlack R, Affi A, Vazquez-Sequeiros E, et al. Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointest Endosc 2002; 56:543-547.
• Bektas M, Lee JH, Guha S, et al. Prevalence of extrapancreatic cysts in patients with cystic neoplasms of the pancreas. American Colloge of Gastroenterology Meeting- San Diago 2009 (poster).
• Melotti G, Butturini G, Piccoli M, et al. Laparoscopic distal pancreatectomy: results on a consecutive series of 58 patients. Ann Surg 2007; 24:77-82.
• Takaori K, Tanigawa N. Laparoscopic pancreatic resection: The past, present, and future. Surg Today 2007; 37:535-545.
• Lee SY, Goh BK, Tan YM, et al. Spleen-preserving distal pancreatectomy. Singapore Med J 2008; 49:883-885.
• Maker AV, Lee LS, Raut CP, Clancy TE, Swanson RS. Cytology from pancreatic cysts has marginal utility in surgical decision-making. Ann Surg Oncol 2008; 15:3187-319.